Literature DB >> 27125304

Decreased Incentive Motivation Following Knockout or Acute Blockade of the Serotonin Transporter: Role of the 5-HT2C Receptor.

Caleb J Browne1,2, Paul J Fletcher1,2,3.   

Abstract

Acute pharmacological elevation of serotonin (5-hydroxytryptamine; 5-HT) activity decreases operant responding for primary reinforcers, suggesting that 5-HT reduces incentive motivation. The mechanism by which 5-HT alters incentive motivation is unknown, but parallel evidence that 5-HT2C receptor agonists also reduce responding for primary reinforcers implicates this receptor as a potential candidate. These experiments examined whether chronic and acute disruptions of serotonin transporter (SERT) activity altered incentive motivation, and whether the 5-HT2C receptor mediated the effects of elevated 5-HT on behavior. To assess incentive motivation, we measured responding for three different reinforcers: a primary reinforcer (saccharin), a conditioned reinforcer (CRf), and an unconditioned sensory reinforcer (USRf). In the chronic condition, responding was compared between SERT knockout (SERT-KO) mice and their wild-type littermates. In the acute condition, responding was examined in wild-type mice following treatment with 10 or 20 mg/kg citalopram, or its vehicle. The ability of the selective 5-HT2C antagonist SB 242084 to prevent the effects of SERT-KO and citalopram on responding was subsequently examined. Both SERT-KO and citalopram reduced responding for saccharin, a CRf, and a USRf. Treatment with SB 242084 enhanced responding for a CRf and a USRf in SERT-KO mice and blocked the effects of citalopram on CRf and USRf responding. However, SB 242084 was unable to prevent the effects of SERT-KO or citalopram on responding for saccharin. These results support a powerful inhibitory function for 5-HT in the control of incentive motivation, and indicate that the 5-HT2C receptor mediates these effects of 5-HT in a reinforcer-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27125304      PMCID: PMC4987855          DOI: 10.1038/npp.2016.63

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  53 in total

Review 1.  Central nervous system control of food intake.

Authors:  M W Schwartz; S C Woods; D Porte; R J Seeley; D G Baskin
Journal:  Nature       Date:  2000-04-06       Impact factor: 49.962

2.  Selective destruction of brain serotonin neurons by 5,7-dihydroxytryptamine increases responding for a conditioned reward.

Authors:  P J Fletcher; K M Korth; J W Chambers
Journal:  Psychopharmacology (Berl)       Date:  1999-12       Impact factor: 4.530

3.  Responding for a conditioned reinforcer, and its enhancement by nicotine, is blocked by dopamine receptor antagonists and a 5-HT(2C) receptor agonist but not by a 5-HT(2A) receptor antagonist.

Authors:  Elizabeth Glenn Guy; Paul J Fletcher
Journal:  Pharmacol Biochem Behav       Date:  2014-08-23       Impact factor: 3.533

4.  Evidence for an involvement of 5-hydroxytryptaminergic neurones in the maintenance of operant behaviour by positive reinforcement.

Authors:  M A Wogar; C M Bradshaw; E Szabadi
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

5.  Effects of cocaine and fenfluramine on progressive-ratio performance.

Authors:  D M Thompson
Journal:  Pharmacol Biochem Behav       Date:  1977-12       Impact factor: 3.533

6.  Influence of individual differences and chronic fluoxetine treatment on cocaine-seeking behavior in rats.

Authors:  D A Baker; T L Tran-Nguyen; R A Fuchs; J L Neisewander
Journal:  Psychopharmacology (Berl)       Date:  2001-04       Impact factor: 4.530

Review 7.  From obesity to substance abuse: therapeutic opportunities for 5-HT2C receptor agonists.

Authors:  Guy A Higgins; Edward M Sellers; Paul J Fletcher
Journal:  Trends Pharmacol Sci       Date:  2013-09-13       Impact factor: 14.819

8.  Stimulation of 5-HT2C receptors attenuates cue and cocaine-primed reinstatement of cocaine-seeking behavior in rats.

Authors:  Janet L Neisewander; Jazmin I Acosta
Journal:  Behav Pharmacol       Date:  2007-12       Impact factor: 2.293

9.  Responding for conditioned reinforcement in C57BL/6 and CD-1 mice, and Sprague-Dawley rats: Effects of methylphenidate and amphetamine.

Authors:  J D Caleb Browne; Ashlie D Soko; Paul J Fletcher
Journal:  Psychopharmacology (Berl)       Date:  2014-05-08       Impact factor: 4.530

Review 10.  Brain dopamine and reward.

Authors:  R A Wise; P P Rompre
Journal:  Annu Rev Psychol       Date:  1989       Impact factor: 24.137

View more
  6 in total

1.  Pharmacological evidence that 5-HT2C receptor blockade selectively improves decision making when rewards are paired with audiovisual cues in a rat gambling task.

Authors:  Wendy K Adams; Chris Barkus; Jacqueline-Marie N Ferland; Trevor Sharp; Catharine A Winstanley
Journal:  Psychopharmacology (Berl)       Date:  2017-07-21       Impact factor: 4.530

2.  Effects of 5-HT1A, 5-HT2A and 5-HT2C receptor agonists and antagonists on responding for a conditioned reinforcer and its enhancement by methylphenidate.

Authors:  Paul J Fletcher; Fiona D Zeeb; Caleb J Browne; Guy A Higgins; Ashlie D Soko
Journal:  Psychopharmacology (Berl)       Date:  2017-01-18       Impact factor: 4.530

3.  Pharmacological Modulation of 5-HT2C Receptor Activity Produces Bidirectional Changes in Locomotor Activity, Responding for a Conditioned Reinforcer, and Mesolimbic DA Release in C57BL/6 Mice.

Authors:  Caleb J Browne; Xiaodong Ji; Guy A Higgins; Paul J Fletcher; Colin Harvey-Lewis
Journal:  Neuropsychopharmacology       Date:  2017-06-13       Impact factor: 7.853

4.  5-HT2C receptor perturbation has bidirectional influence over instrumental vigour and restraint.

Authors:  Oliver Härmson; Laura L Grima; Marios C Panayi; Masud Husain; Mark E Walton
Journal:  Psychopharmacology (Berl)       Date:  2021-11-11       Impact factor: 4.530

5.  The Combination of Galanin (1-15) and Escitalopram in Rats Suggests a New Strategy for Alcohol Use Disorder Comorbidity with Depression.

Authors:  Noelia Cantero-García; Antonio Flores-Burgess; David Ladrón de Guevara-Miranda; Antonia Serrano; Laura García-Durán; Araceli Puigcerver; Kjell Fuxe; José Ángel Narváez; Luis Javier Santín; Zaida Díaz-Cabiale; Carmelo Millón
Journal:  Biomedicines       Date:  2022-02-09

6.  A single dose of escitalopram blunts the neural response in the thalamus and caudate during monetary loss.

Authors:  Carolin A Lewis; Karsten Mueller; Rachel G Zsido; Janis Reinelt; Ralf Regenthal; Hadas Okon-Singer; Erika E Forbes; Arno Villringer; Julia Sacher
Journal:  J Psychiatry Neurosci       Date:  2021-04-27       Impact factor: 6.186

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.